Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients.
作者信息
Zauli Giorgio, Tisato Veronica, Secchiero Paola
机构信息
Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
出版信息
Front Pharmacol. 2020 Jul 29;11:1156. doi: 10.3389/fphar.2020.01156. eCollection 2020.
Abstract
摘要
Zotero 插件